Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,267 | 4 | 83.5% |
| Food and Beverage | $1,268 | 88 | 14.6% |
| Consulting Fee | $150.00 | 1 | 1.7% |
| Gift | $14.05 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $7,361 | 10 | $0 (2017) |
| Alkermes, Inc. | $150.00 | 1 | $0 (2017) |
| Allergan, Inc. | $143.98 | 17 | $0 (2021) |
| Biogen, Inc. | $138.76 | 16 | $0 (2021) |
| PFIZER INC. | $113.68 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $99.69 | 5 | $0 (2024) |
| EMD Serono, Inc. | $93.60 | 6 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $81.54 | 4 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $75.84 | 2 | $0 (2021) |
| Celgene Corporation | $62.48 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79.90 | 4 | PFIZER INC. ($37.66) |
| 2023 | $91.37 | 6 | PFIZER INC. ($32.66) |
| 2022 | $172.15 | 10 | EMD Serono, Inc. ($41.91) |
| 2021 | $184.61 | 9 | Alexion Pharmaceuticals, Inc. ($53.50) |
| 2018 | $12.18 | 1 | Lilly USA, LLC ($12.18) |
| 2017 | $8,158 | 64 | Supernus Pharmaceuticals, Inc. ($7,361) |
All Payment Transactions
94 individual payment records from CMS Open Payments — Page 3 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2017 | Mitsubishi Tanabe Pharma America, Inc. | Radicava (Drug) | Food and Beverage | Cash or cash equivalent | $12.44 | General |
| Category: Amyotrophic Lateral Sclerosis | ||||||
| 07/07/2017 | Allergan Inc. | NAMZARIC (Drug), NAMENDA XR | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,667.00 | General |
| Category: AED | ||||||
| 06/30/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| Category: AED | ||||||
| 06/30/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $12.50 | General |
| Category: AED | ||||||
| 06/30/2017 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $2.88 | General |
| 06/22/2017 | Allergan Inc. | NAMZARIC (Drug), NAMENDA XR | Food and Beverage | In-kind items and services | $4.08 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2017 | Impax Laboratories, Inc. | RYTARY (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: NEUROLOGY | ||||||
| 06/16/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: NEUROLOGY | ||||||
| 06/06/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: PDP | ||||||
| 05/24/2017 | Allergan Inc. | NAMZARIC (Drug), NAMENDA XR | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: NEUROLOGY | ||||||
| 05/23/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/16/2017 | Biogen, Inc. | TECFIDERA (Drug), ZINBRYTA | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: NEUROLOGY | ||||||
| 05/16/2017 | Biogen, Inc. | TECFIDERA (Drug), ZINBRYTA | Food and Beverage | In-kind items and services | $2.12 | General |
| Category: NEUROLOGY | ||||||
| 05/09/2017 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $36.01 | General |
| Category: Neurology | ||||||
| 05/05/2017 | Alkermes, Inc. | — | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| 05/02/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: NEUROLOGY | ||||||
| 05/02/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: AED | ||||||
| 04/28/2017 | Supernus Pharmaceuticals, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.05 | General |
| 04/26/2017 | Allergan Inc. | NAMZARIC (Drug), NAMENDA XR | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,292 | 22,263 | $1.5M | $384,971 |
| 2022 | 9 | 1,465 | 20,410 | $1.5M | $431,610 |
| 2021 | 11 | 1,207 | 14,787 | $1.3M | $338,248 |
| 2020 | 12 | 1,034 | 10,774 | $1.1M | $244,116 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 31 | 20,645 | $206,450 | $102,333 | 49.6% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2023 | 210 | 210 | $315,000 | $82,575 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 281 | 468 | $269,833 | $46,749 | 17.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 205 | 276 | $224,355 | $42,232 | 18.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 200 | 200 | $179,400 | $35,864 | 20.0% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 136 | 136 | $81,600 | $33,728 | 41.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 136 | 136 | $88,400 | $18,842 | 21.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 35 | 113 | $73,450 | $14,517 | 19.8% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 18 | 39 | $78,000 | $6,831 | 8.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 40 | 40 | $22,000 | $1,300 | 5.9% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Office | 2022 | 254 | 258 | $387,000 | $104,476 | 27.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 27 | 18,600 | $186,000 | $90,762 | 48.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 282 | 282 | $211,500 | $53,648 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 281 | 483 | $169,050 | $50,548 | 29.9% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 181 | 181 | $108,600 | $47,127 | 43.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 121 | 174 | $69,600 | $27,295 | 39.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 182 | 182 | $118,300 | $26,666 | 22.5% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 44 | 87 | $174,000 | $15,654 | 9.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 31 | 101 | $65,650 | $13,357 | 20.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2022 | 62 | 62 | $34,200 | $2,077 | 6.1% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Office | 2021 | 187 | 187 | $280,500 | $75,951 | 27.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 22 | 13,200 | $132,000 | $64,116 | 48.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 272 | 492 | $172,200 | $47,253 | 27.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 192 | 192 | $144,000 | $37,557 | 26.1% |
| 93886 | Ultrasound scanning of head and neck vessel blood flow (inside the brain) | Office | 2021 | 123 | 124 | $74,400 | $32,464 | 43.6% |
About Dr. Michael Silverstein, M.D
Dr. Michael Silverstein, M.D is a Specialist healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2008. The National Provider Identifier (NPI) number assigned to this provider is 1255587366.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Silverstein, M.D has received a total of $8,699 in payments from pharmaceutical and medical device companies, with $79.90 received in 2024. These payments were reported across 94 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,267).
As a Medicare-enrolled provider, Silverstein has provided services to 4,998 Medicare beneficiaries, totaling 68,234 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Hackensack, NJ
- Active Since 08/09/2008
- Last Updated 11/03/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255587366
Products in Payments
- TROKENDI XR (Drug) $7,341
- KESIMPTA (Drug) $99.69
- NAMZARIC (Drug) $92.30
- NURTEC ODT (Drug) $85.88
- TYSABRI (Biological) $85.08
- COPAXONE (Drug) $81.54
- ZEPOSIA (Drug) $62.48
- Fycompa (Drug) $56.70
- Soliris (Drug) $53.50
- NUPLAZID (Drug) $43.96
- Rebif (Biological) $37.34
- RYTARY (Drug) $37.12
- BOTOX (Biological) $35.38
- TECFIDERA (Drug) $32.59
- LYRICA (Drug) $26.51
- Trudhesa (Drug) $23.07
- SOLIRIS (Drug) $22.34
- CALA TRIO (Device) $21.69
- OCREVUS (Biological) $18.71
- Briviact (Drug) $18.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Hackensack
Dr. Mario Vukic, Md, MD
Specialist — Payments: $161,597
Dr. Deborah Goss, Md, MD
Specialist — Payments: $25,504
Dr. Damon Fellman, Md, MD
Specialist — Payments: $15,359
Dr. Sarika Sharma, M.d, M.D
Specialist — Payments: $13,589
Mr. Scott Ruffo, Md, MD
Specialist — Payments: $12,729
Dr. Thomas Selvaggi, M.d, M.D
Specialist — Payments: $11,640